WHO-sponsored meeting discusses post-2015 goals for tuberculosis

NewsGuard 100/100 Score

Tuberculosis (TB) experts gathered in Geneva on Wednesday for a WHO-sponsored two-day meeting "to discuss a consensus on the appropriate post-2015 tuberculosis goals," Nature reports. In the 2015 Millennium Development Goals, TB is named under Goal 6, with the objective of reducing global TB incidence, but "the tuberculosis community is itching to get its goals included with more definition in the post-2015 development agenda," the journal notes. According to Nature, "The gathering will be tense. Although the stakeholders all hope to eliminate the pulmonary disease that kills about 1.4 million people worldwide each year, they disagree about what the next 10-year objective should be."

One possible goal "would be to cut the projected 2015 annual deaths in half by 2025," which Mario Raviglione, director of the WHO's Stop TB Department, "calls ... feasible yet challenging enough to drive change, given the imperfect tools to prevent, diagnose and treat tuberculosis that currently exist," Nature writes. "But some of his contemporaries say that the 50 percent target will not inspire sufficient action and enthusiasm," according to the journal, which notes that while global TB mortality has declined, TB deaths are not decreasing in some regions, including Eastern Europe and Africa. Nature includes comments from other experts and discusses new drugs recently approved and in clinical trials for TB treatment (Maxmen, 2/6). In related news, Al Jazeera's "Inside Story" examines a new study showing fake and substandard TB medicines in developing countries are making the disease more difficult to treat (Kyle, 2/6). 


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New study finds interferon-γ release assays more effective than skin tests in predicting tuberculosis